It was reported the coapt post-approval study (pas) is a prospective, single arm, multi-center, observational real-world surveillance plan to confirm the long-term safety and effectiveness of the mitraclip¿ system in hf patients with smr.The annual follow-up data identified an atrial septal defect requiring closure was obtained by linkage to the cms fee-for-service (ffs) claims database.Additional information was be found in the attached report, titled ¿the coapt secondary mr post-approval study annual progress report 2023.¿.
|
The device was not returned for analysis.A review of the lot history record (lhr) and corrective action tracking system for the web (catsweb) database for the reported lot could not be performed as the lot number and part number are unknown.Based on the information reviewed, and due to limited information available from the article the cause for the reported perforation could not be determined.The reported perforation is listed in the instructions for use (ifu) and is a known possible complication associated with mitraclip procedures.The reported medical intervention was the results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|